ArticleNeuro-oncology2023

Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas.

Mark W Youngblood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.